| |
| |
|
| Insider
Information: |
Lang Matthew |
| Relationship: |
Chief Business Officer |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
50,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$116,500 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
50,000 |
|
|
| Total
Value |
$116,500 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
11
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.7
|
| Percentage
Gain/Loss : |
0.0%
|
 498.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myovant Sciences Ltd. |
MYOV |
General Counsel & Corp... |
2023-03-10 |
0 |
|
0 |
Premium* |
|
|
Lyell Immunopharma, Inc. |
LYEL |
Chief Business Officer |
2024-02-09 |
50,000 |
2024-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LYEL |
Lyell Immunopharma, Inc. |
Chief Business Officer |
• – – |
2024-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2023-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(354,303) |
0 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2023-01-18 |
4 |
S |
$26.89 |
$34,204 |
D/D |
(1,272) |
354,303 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2023-01-04 |
4 |
S |
$26.90 |
$74,755 |
D/D |
(2,779) |
355,575 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-10-18 |
4 |
S |
$25.20 |
$48,712 |
D/D |
(1,933) |
358,354 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-10-04 |
4 |
S |
$24.40 |
$89,768 |
D/D |
(3,679) |
360,287 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-08-15 |
4 |
S |
$18.23 |
$569,031 |
D/D |
(31,214) |
363,966 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
124,780 |
395,180 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-07-18 |
4 |
S |
$12.87 |
$24,903 |
D/D |
(1,935) |
270,400 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-07-06 |
4 |
S |
$13.40 |
$49,607 |
D/D |
(3,702) |
272,335 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-04-19 |
4 |
S |
$10.45 |
$83,621 |
D/D |
(8,002) |
276,037 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
111,111 |
284,039 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-04-05 |
4 |
S |
$13.78 |
$33,568 |
D/D |
(2,436) |
172,928 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2022-01-04 |
4 |
S |
$16.27 |
$72,808 |
D/D |
(4,475) |
175,364 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2021-10-05 |
4 |
S |
$21.62 |
$144,227 |
D/D |
(6,671) |
179,839 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2021-07-09 |
4 |
S |
$21.52 |
$149,650 |
D/D |
(6,954) |
186,510 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2021-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
58,461 |
193,464 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2021-04-06 |
4 |
S |
$18.62 |
$202,250 |
D/D |
(10,862) |
135,003 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2021-03-15 |
4 |
AS |
$25.07 |
$752,013 |
D/D |
(30,000) |
145,865 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2021-03-15 |
4 |
OE |
$7.78 |
$233,400 |
D/D |
30,000 |
175,865 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2020-12-18 |
4 |
AS |
$25.38 |
$254,054 |
D/D |
(10,000) |
145,865 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2020-12-18 |
4 |
OE |
$7.78 |
$77,800 |
D/D |
10,000 |
155,865 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2020-12-10 |
4 |
AS |
$25.20 |
$488,783 |
D/D |
(19,400) |
145,865 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2020-12-10 |
4 |
OE |
$7.78 |
$150,932 |
D/D |
19,400 |
165,265 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
General Counsel & Corp. Secy. |
• – – |
2020-12-09 |
4 |
OE |
$7.78 |
$4,668 |
D/D |
600 |
146,465 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
